Clinical investigation on coexisting of duodenal ulcer and gastric cancer in China

International Journal of Clinical Practice

Volumn 59, Issue 10, 2005, Pages 1153-1156

  Zhao, L ^a   Shen, Z X ^a   Luo, H S ^a   Yu, J P ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Coexistence; Duodenal ulcer; Gastric cancer

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; UREASE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CHINA; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DUODENUM ULCER; ENDOSCOPY; ENZYME ASSAY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROSCOPY; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; STOMACH CANCER; UNIVERSITY HOSPITAL; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

AGED; DUODENAL ULCER; FEMALE; GASTROSCOPY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 33644835229     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2005.00594.x     Document Type: Article

References (29)

1. Valle J, Kekki M, Sipponen P, Ihamaki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996; 31: 546-50.
2. Sipponen P, Stolte M. Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 1997; 29: 671-8.
3. Madsen JE, Vetvik K, Aase S. Helicobacter pylori and chronic active inflammation of the duodenum and stomach in duodenal ulcer patients treated with ranitidine, misoprostol, or an acid-neutralizing agent. Scand J Gastroenterol 1991; 26: 465-70.
4. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
5. McColl KE, el-Omar E, Gillen D. Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am 2000; 29: 687-703, viii.
6. Rood JC, Ruiz B, Fontham ETH et al. Helicobacter pylori -associated gastritis and the ascorbic acid concentration in gastric juice. Nutr Cancer 1994; 22: 65-72.
7. Lechago J, Correa P. Prolonged achlorhydria and gastric neoplasia: A causal relationship? Gastroenterology 1993; 104: 554-557.
8. Graham DY. Helicobacter pylori: Its epidemiology and its role in duodenal ulcer disease. J Gastroenterol 1991; 6: 105-13.
9. Fisher A, Clagett OT, McDonald JR. Coexisting duodenal ulcer and gastric malignancy. Surgery 1947; 2: 168-74.
10. Bum GP, Taubman J. The association of gastric cancer and duodenal ulcer. Br J Surg 1967; 54: 174-6.
11. Lewis JH, Woods M III. Gastric carcinoma in patients with unoperated duodenal ulcer disease. Am J Gastroenterol 1982; 77: 368-73.
12. Lee S, Iida M, Yao T et al. Risk of gastric cancer in patients with non-surgically treated peptic ulcer. Scand J Gastroenterol 1990; 25: 1223-6.
13. Hansson LE, Nyren O, Hsing AW et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-9.
14. Molloy RM, Sonnenberg A. Relation between gastric cancer and previous peptic ulcer disease. Gut 1997; 40: 247-52.
15. Roder DM. The epidemiology of gastric cancer. Gastric Cancer 2002; 5 (Suppl. 1): 5-11.
16. Lewin KJ, Riddell RH, Weinstein WM. Gastrointestinal Pathology and its Clinical Implication NewYork/Tokyo: Igaku-Shoin, 1992: 624.
17. Borrmann R. Geshwulste des Magens und Duodenums. In: Henker F, Lubarsh D, eds. Handbuchder Spezieller Pathologischen, Volume IV, Anatomie und Histolgie Berlin: Springer-Verlag, 1926: 865.
18. Haubrich WS, Edmonson JM. History of endoscopy. In: Sivak MV. Gastroenterologic Endoscopy, 2nd edn. Philadelphia: Saunders WB 2000: 615-36.
19. Hicks S. Gastric cancer: Diagnosis, risk factor, treatment and life issues. Br J Nurs 2001; 10: 529-36.
20. Kim HY, Kim YB, Park CK, Yoo JY, Graham DY. Co-existing gastric cancer and duodenal ulcer disease: Role of Helicobacter pylori infection. Helicobacter 1997; 2: 205-9.
21. Chang FY, Lee O, Lee SD. Coexistent duodenal ulcer among patients with gastric carcinoma. S Afr Med J 1994; 84: 618-21.
22. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: The immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000; 54: 615-40.
23. Furuta T, El-Omar EM, Xiao F et al. Interleukin 1 beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123: 92-105.
24. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
25. Figueiredo C, Van Doorn LJ, Nogueira C et al. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 2001; 36: 128-35.
26. El-Zimaity HMT, Gutierrez O, Kim JG et al. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol 2001; 96: 666-72.
27. Kuipers EJ, Uyterlinde AM, Pena AS et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1995; 90: 1401-6.
28. Zerbib F, Lenk C, Sawan B et al. Long-term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patients. Eur J Gastroenterol Hepatol 2000; 12: 719-25.
29. Kim N, Lim SH, Lee KH et al. Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers. Dig Dis Sci 2000; 45: 1754-62.